{"id":"misoprostol-pill","safety":{"commonSideEffects":[{"rate":"13-40","effect":"Diarrhea"},{"rate":"13-20","effect":"Abdominal pain"},{"rate":"3-7","effect":"Nausea"},{"rate":null,"effect":"Uterine cramping"},{"rate":null,"effect":"Vaginal bleeding"}]},"_chembl":{"chemblId":"CHEMBL4064157","moleculeType":"Small molecule","molecularWeight":"382.54"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Misoprostol acts as a synthetic prostaglandin that activates EP3 and other prostaglandin receptors on gastric mucosa, enhancing protective mucus secretion and bicarbonate production while simultaneously decreasing gastric acid output. This dual mechanism protects the gastric lining from ulceration. Additionally, misoprostol has uterotonic properties, causing uterine contractions, which is the basis for its use in obstetrics and gynecology.","oneSentence":"Misoprostol is a prostaglandin E1 analog that binds to prostaglandin receptors to increase gastric mucus production and reduce gastric acid secretion.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:55:20.822Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers"},{"name":"Medical abortion (in combination with mifepristone)"},{"name":"Treatment of gastric ulcers"}]},"trialDetails":[{"nctId":"NCT04940013","phase":"PHASE4","title":"Missed Period Pill Study","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2021-10-25","conditions":"Menstrual Regulation, Menstrual Irregularity","enrollment":17},{"nctId":"NCT05342974","phase":"EARLY_PHASE1","title":"Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy","status":"COMPLETED","sponsor":"University of Utah","startDate":"2022-04-19","conditions":"Abortion Early","enrollment":9},{"nctId":"NCT01862991","phase":"NA","title":"Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services","status":"COMPLETED","sponsor":"Stanford University","startDate":"2013-07","conditions":"Legally Induced Abortion Without Mention of Complication","enrollment":80},{"nctId":"NCT05928871","phase":"PHASE4","title":"Pre Versus Post-operative Misoprostol in Reducing Blood Loss After Cesarean Section","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-06-01","conditions":"Misoprostol Allergy","enrollment":120},{"nctId":"NCT05216952","phase":"PHASE2","title":"Ulipristal Acetate for Use in Early Pregnancy Loss","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-05-11","conditions":"Missed Abortion, Anembryonic Pregnancy, Non-Viable Pregnancy","enrollment":3},{"nctId":"NCT04941443","phase":"PHASE4","title":"Methadone and Medication Abortion","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2021-10-04","conditions":"Pain, Medical Abortion","enrollment":4},{"nctId":"NCT02412618","phase":"PHASE4","title":"Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2012-09","conditions":"Induced Abortion","enrollment":100},{"nctId":"NCT05124314","phase":"PHASE4","title":"Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss","status":"UNKNOWN","sponsor":"Clinical Hospital Merkur","startDate":"2021-10-27","conditions":"Abortion, Missed","enrollment":220},{"nctId":"NCT03727308","phase":"","title":"Study of Clinic-based Versus Self-use of Medical Abortion Pills","status":"COMPLETED","sponsor":"Ipas","startDate":"2018-05-30","conditions":"Induced Abortion, First Trimester Abortion, Misoprostol","enrollment":4196},{"nctId":"NCT05001061","phase":"EARLY_PHASE1","title":"Sublingual vs Vaginal Misoprostol for Termination of First Trimesteric Missed Abortion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2021-08-03","conditions":"Missed Abortion","enrollment":288},{"nctId":"NCT02704481","phase":"PHASE4","title":"Non-surgical Alternatives to Treatment of Failed Medical Abortion","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2016-06-01","conditions":"Abortion Failure","enrollment":16},{"nctId":"NCT04063904","phase":"PHASE4","title":"Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2019-10-16","conditions":"Second Trimester Abortion","enrollment":16},{"nctId":"NCT03002441","phase":"NA","title":"Same-day Cervical Preparation Before Dilation and Evacuation","status":"COMPLETED","sponsor":"Planned Parenthood of Greater New York","startDate":"2016-12","conditions":"Cervical Dilation Prior to Dilation and Evacuation","enrollment":54},{"nctId":"NCT04780412","phase":"PHASE3","title":"Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-09-01","conditions":"Transient Tachypnea of the Newborn, Neonatal Respiratory Distress","enrollment":210},{"nctId":"NCT03939663","phase":"PHASE2","title":"Role of Vaginal Misoprostol Prior to IUCD Insertion in Women Who Delivered Only by Elective Caesarean Section.","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2018-07-01","conditions":"IUD Insertion Complication","enrollment":210},{"nctId":"NCT02342002","phase":"PHASE4","title":"Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2015-01","conditions":"Missed Abortion, Pregnancy","enrollment":416},{"nctId":"NCT01147497","phase":"NA","title":"Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women","status":"COMPLETED","sponsor":"Emory University","startDate":"2010-06","conditions":"Contraception","enrollment":78},{"nctId":"NCT03248050","phase":"NA","title":"Evaluating an Intervention to Increase Use of Call Centre Support for Self-managed Medical Abortion","status":"UNKNOWN","sponsor":"Marie Stopes International","startDate":"2017-10-15","conditions":"Abortion, Drug-Induced, Pharmacies","enrollment":1359},{"nctId":"NCT01422226","phase":"NA","title":"Intra Uterine Device Insertion in Nulliparous Women","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2011-07","conditions":"Contraception","enrollment":3},{"nctId":"NCT01519765","phase":"PHASE4","title":"Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2011-07","conditions":"Pregnancy","enrollment":73},{"nctId":"NCT01307111","phase":"NA","title":"Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2011-02","conditions":"Pain","enrollment":85},{"nctId":"NCT02409407","phase":"PHASE2","title":"Misoprostol Before Hysteroscopy in Infertile Cases","status":"UNKNOWN","sponsor":"Kasr El Aini Hospital","startDate":"2015-04","conditions":"Infertility","enrollment":120},{"nctId":"NCT00886834","phase":"NA","title":"Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women","status":"COMPLETED","sponsor":"University of Utah","startDate":"2009-04","conditions":"Contraception","enrollment":108},{"nctId":"NCT01718314","phase":"NA","title":"Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Hysteroscopy","status":"COMPLETED","sponsor":"Dr. Sami Ulus Children's Hospital","startDate":"2008-03","conditions":"Pain During Hysteroscopy","enrollment":138},{"nctId":"NCT01231126","phase":"PHASE4","title":"Evaluation the Blood Loss in Pregnancies With Misoprostol-induced Labour","status":"COMPLETED","sponsor":"Maternidade Escola Assis Chateaubriand","startDate":"2008-02","conditions":"Pregnancy, Induced Labor","enrollment":161}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":44,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cytotec","Mispregnol","misotac"],"phase":"marketed","status":"active","brandName":"Misoprostol Pill","genericName":"Misoprostol Pill","companyName":"University of North Carolina, Chapel Hill","companyId":"university-of-north-carolina-chapel-hill","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Misoprostol is a small molecule medication used in medical research for conditions such as induced abortion, first trimester abortion, and contraception. It is administered as an intervention in clinical trials, often compared to a placebo or medical abortion pills sourced from pharmacies.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}